ARCHIVES

Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS

This article is from The Cancer Letter archive.

Vol. 17 No. 37 | September 27, 1991

Download PDF Visit The Full Archive

Related Articles

New Risk Stratification Method For Prostate Cancer Described

November 28, 2003

FDA Hazleton Probe Finds Some Problems; Results Unaffected

April 23, 1976

Survey Show Better Understanding Of Breast Cancer

December 12, 1980

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

Non-Chemo Agents Added To Regimens For Lymphomas

January 26, 2007

Chemical Industry Sues NTP Over Listing PDC As Carcinogen; Environmental Groups Join Defense

June 23, 1989